Search PDMR transactions

Notifier
Name of person with notification obligation
Lars Peter Fredell
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Lars Peter Fredell
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
vimab group ab
Issuer´s LEI code
549300FVB4OI2UM83V72
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share vimab group aktie SE0007439633 Acquisition 7,000 Quantity 6.74 SEK 29/09/2025 NASDAQ STOCKHOLM AB
Share vimab group aktie SE0007439633 Acquisition 5,000 Quantity 6.80 SEK 30/09/2025 NASDAQ STOCKHOLM AB
Share vimab group aktie SE0007439633 Acquisition 5,000 Quantity 7.00 SEK 01/10/2025 NASDAQ STOCKHOLM AB
Share vimab group aktie SE0007439633 Acquisition 10,000 Quantity 7.00 SEK 02/10/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
vimab group aktie SE0007439633 Acquisition 29/09/2025 NASDAQ STOCKHOLM AB 7,000 (Quantity) 6.74 SEK
vimab group aktie SE0007439633 Acquisition 30/09/2025 NASDAQ STOCKHOLM AB 5,000 (Quantity) 6.80 SEK
vimab group aktie SE0007439633 Acquisition 01/10/2025 NASDAQ STOCKHOLM AB 5,000 (Quantity) 7.00 SEK
vimab group aktie SE0007439633 Acquisition 02/10/2025 NASDAQ STOCKHOLM AB 10,000 (Quantity) 7.00 SEK
Total: 27,000
<< Back